The American Society of Hematology meeting is back for 2021, at least partially, taking place as a hybrid conference online and in person in Atlanta 11-14 December, with a variety of companies showcasing their latest clinical findings in hematological cancers and blood disorders.
Below is a selection of data appearing at this year’s ASH meeting that have been generating buzz among analysts.



![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

